{"entity":{"type":"insider","cik":"0001317190","url":"/insider/0001317190","json_url":"/insider/0001317190.json","name":"Jeong Tae Heum","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":3,"first":"2008-04-23","last":"2015-01-12","span_basis":"filed_date"},"name_variants":[{"name":"Jeong Tae Heum","source":"filing","n_filings":3,"first_seen":"2008-04-23","last_seen":"2015-01-12"}],"transactions":[{"id":8781145,"accession":"0001140361-15-001483","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001140361-15-001483","line_url":"/filing/0001140361-15-001483#line-6","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001317190","owner_name":"Jeong Tae Heum","owner_display_name":"Jeong Tae Heum","owner_url":"/insider/0001317190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":49800.0,"shares_display":"49,800","price_per_share":0.9135,"price_display":"0.91","price_state":"stated","total_value":45492.3,"total_display":"45,492.30","total_whole":"45,492","shares_owned_after":505000.0,"shares_owned_after_display":"505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-12","filed_date":"2015-01-12","scope":"insider"},{"id":8781143,"accession":"0001140361-15-001483","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001140361-15-001483","line_url":"/filing/0001140361-15-001483#line-4","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001317190","owner_name":"Jeong Tae Heum","owner_display_name":"Jeong Tae Heum","owner_url":"/insider/0001317190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":188690.0,"shares_display":"188,690","price_per_share":0.9153,"price_display":"0.92","price_state":"stated","total_value":172707.957,"total_display":"172,707.96","total_whole":"172,708","shares_owned_after":505000.0,"shares_owned_after_display":"505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-09","filed_date":"2015-01-12","scope":"insider"},{"id":8781141,"accession":"0001140361-15-001483","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-001483","line_url":"/filing/0001140361-15-001483#line-2","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001317190","owner_name":"Jeong Tae Heum","owner_display_name":"Jeong Tae Heum","owner_url":"/insider/0001317190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":78782.0,"shares_display":"78,782","price_per_share":0.9004,"price_display":"0.90","price_state":"stated","total_value":70935.3128,"total_display":"70,935.31","total_whole":"70,935","shares_owned_after":505000.0,"shares_owned_after_display":"505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-08","filed_date":"2015-01-12","scope":"insider"},{"id":4650946,"accession":"0001140361-13-035677","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001140361-13-035677","line_url":"/filing/0001140361-13-035677#line-3","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RNN","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001317190","owner_name":"Jeong Tae Heum","owner_display_name":"Jeong Tae Heum","owner_url":"/insider/0001317190","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":71139.0,"shares_display":"71,139","price_per_share":0.4565,"price_display":"0.46","price_state":"stated","total_value":32474.9535,"total_display":"32,474.95","total_whole":"32,475","shares_owned_after":505000.0,"shares_owned_after_display":"505,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-09-09","filed_date":"2013-09-11","scope":"insider"},{"id":2676256,"accession":"0001140361-08-010051","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-08-010051","line_url":"/filing/0001140361-08-010051","is_derivative":false,"issuer_cik":"0001228627","issuer_name":"REXAHN PHARMACEUTICALS, INC.","issuer_ticker":"RXHN.OB","issuer_name_source":null,"issuer_url":"/issuer/0001228627","owner_cik":"0001317190","owner_name":"Jeong Tae Heum","owner_display_name":"Jeong Tae Heum","owner_url":"/insider/0001317190","role":"Director, Officer (CFO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":2.2564,"price_display":"2.26","price_state":"stated","total_value":11282.0,"total_display":"11,282.00","total_whole":"11,282","shares_owned_after":503700.0,"shares_owned_after_display":"503,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-22","filed_date":"2008-04-23","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":2,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001228627","name":"REXAHN PHARMACEUTICALS, INC.","url":"/issuer/0001228627","role":"Director, Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2008-04-23","last_seen":"2015-01-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001317190","retrieved_at":"2026-08-25T05:05:01+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}